AbbVie: Who we are · AbbVie: Who we are US-ABBV-200135 AbbVie has as long history in healthcare dating back to 1888 with Abbott 3 130+ years of patient care Millions of lives touched

AbbVie: Who we are

AbbVie: Who we are US-ABBV-200135

At AbbVie, we strive

to make a remarkable

impact on the lives of

patients.

2


AbbVie has as long history in healthcare dating

back to 1888 with Abbott

3

130+ years of patient care

Millions of lives touched

Launched as AbbVie in

2013

AbbVie: Who we are US-ABBV-200135 AbbVie: Who we are US-ABBV-200135

AbbVie’s Mission

Create an innovation-driven, patient-

focused specialty biopharmaceutical

company capable of achieving sustainable

top-tier performance through outstanding

execution and a consistent stream of

innovative new medicines which have a

remarkable impact on

people’s lives.

4AbbVie: Who we are US-ABBV-200135


With Allergan, AbbVie has an expanded global footprint of

state-of-the-art facilities

Ludwigshafen, Germany

Tokyo, Japan

Massachusetts, USA:

Cambridge

Worcester

Illinois, USA:

Lake County

North Chicago

California, USA:

Redwood City

San Francisco

Sunnyvale

5

Texas, USA:

Houston

Waco

Cincinnati, OH, USA

New Jersey, USA:

Branchburg

Madison

California, USA:

Campbell

Dublin/Pleasanton

Irvine

Heredia, Costa Rica

Marlow, United Kingdom

Ireland:

Dublin

Galway

Westport

Pringy, France

Grâce-Hollogne, Belgium

Grande Guarulhos, Brazil

Michigan, USA

Wyandotte

Barceloneta,

Puerto Rico (2)

Ireland:

Ballytivnan

Cork

Sligo

Campoverde, Italy

Singapore, Singapore

AbbVie facilities

Allergan facilities *Not all sites pictured


We have market leadership in attractive growth

segments

6

#1Immunology

#2Hematologic

oncology

#1Aesthetics

Leadership

in Women’s

health

#1Global HCV

Leadership

in Eye care


Therapeutic areas of focus: Immunology

We leverage deep scientific expertise to

develop next-generation biologics and small

molecules in rheumatology, dermatology and

gastroenterology.

AbbVie medicines in immunology currently treat +1

million patients in 15 indications worldwide.

7


Therapeutic areas of focus: Oncology

8

Current treatment areas:

Acute Myeloid Leukemia

Chronic Graft vs Host Disease

Chronic Lymphocytic Leukemia

Mantle Cell Lymphoma

Marginal Zone Lymphoma

Waldenstrom’s Macroglobulinemia

Future areas of focus:

Immuno-oncology

Apoptosis/B-cell receptor field


Diseases:

• Alzheimer’s disease

• Bipolar disorder

• Bipolar Depression

• Chronic migraine

• Multiple sclerosis

• Overactive bladder

• Parkinson’s disease

• Schizophrenia

Additional Indications:

• Adult Focal Spasticity

• Blepharospasm

• Cervical Dystonia

• Pediatric Upper Limb

Spasticity

• Severe Axillary

Hyperhidrosis

• Strabismus

Therapeutic areas of focus: Neuroscience

We’re researching and developing new, innovative, disease-modifying solutions to address

some of the most difficult-to-treat neurodegenerative diseases.

9


Therapeutic areas of focus: Eye Care

Currently treating:

Glaucoma

Ocular hypertension

Other conditions

Researching areas:

Retina-related diseases, such as

macular edema

Diabetic macular edema

Age-related macular degeneration

10


Therapeutic areas of focus: Virology

We are the global leader in HCV

Despite the availability of a cure, most people with

HCV are untreated and in the earlier stages of liver

disease.

Together with the HCV community, AbbVie is a

committed member of the global movement towards

HCV elimination with the goal to eliminate hepatitis C

by 2030.

11

AbbVie: Who we are US-ABBV-200135 AbbVie: Who we are

Other specialties

Focused investments in areas that fit our core strengths include:

Cardiology

Gastroenterology

General medicine

Women’s health

12


#1 leadership position with world-renowned

brands

Current treatments:

Body contouring

Facial injectables

Plastics

Regenerative medicine

Skin care

13


Together, we have even greater ability to

meet the needs of patients

14

Allergan Aesthetics

AbbVie Therapeutic Areas

Immunology Oncology Neuroscience Eye Care Virology Women’s Health Other specialty

• General medicine

across

30+brands

in more than

175+ countries

Treating

~60 conditions

AbbVie: Who we are US-ABBV-200135 15

AbbVie: Who we are US-ABBV-200135 16


Driving innovation

Transforming lives

Embracing diversity and

inclusion

17

We recognize that health is of fundamental importance to all people. To participate over the

long term in the provision of health care, we must earn and maintain the trust of patients,

health care providers, regulators, policymakers, and

the public.

Creating real health improvement is not only our

mission, but also how we stay competitive. To be a leading

health care innovator, we must attract, retain and support a

diverse workforce and invest in their efforts to develop

medicines that bring value for patients.

For any enterprise to be successful, it must operate in a

healthy business environment. We have the opportunity to use our

unique resources to support well-being, resilience and growth in the

communities where we do business and help lay the

foundation for broader community vitality.

We strive to make a remarkable impact on patients and drive sustainable growth by discovering and

delivering a consistent stream of innovative medicines that address serious health problems.

Corporate strategy:

Responsibility Commitments: USE OUR EXPERTISE TO

IMPROVE HEALTH

SUPPORT LONG-TERM

COMMUNITY STRENGTHSTEWARD OUR ETHICAL AND

SUSTAINABLE BUSINESS

Principles:Acting with integrity Serving the community

AbbVie’s Commitment to

Corporate Responsibility


#AbbVieGivesBack: www.abbvie.com/responsibility

Employee Giving

AbbVie Foundation

matches employee

donations dollar for

dollar to nonprofits

across the globe.

18

Global Week of

Volunteerism

Week of

Possibilities unites

AbbVie employees

around the world

with a single

purpose: to give

back to our local

communities.

Philanthropic Giving

Dedicated to making a remarkable impact on the lives of underserved by supporting programs that build strong communities, effective educational programs and sustainable health care systems.

Engaging Children in STEM

The AbbVie Foundation SEEK Program introduces underserved students to the nature of science and engineering through fun, participatory activities. The program has been translated into 12 languages.

Supporting

Employees During

Pivotal Moments

The AEAF provides

scholarships for

employees’ children

and financial

assistance for

employees in times of

disaster or hardship.


Our commitment to the

environment is ongoing

of purchased electricity

came from renewable

sources

19

New environmental

sustainability projects

approved through

SPARK

10

24%


External recognition as a top company

Workplace & Diversity

DiversityInc. “Top 50 Companies for

Diversity”

FORTUNE “100 Best

Companies to Work For”

Great Places to Work “World’s Best

Workplaces”

Human Rights Campaign Corporate

Equality Index

Science Magazine’s Top Employers

Working Mother “100 Best

Companies”

Business

Performance

FORTUNE 100

FORTUNE World’s Most Admired

Companies

IDEA Pharma Innovation Index

Pharma Reptrak Most Reputable

Companies

Environment, Social

and Governance

Dow Jones Sustainability World

Index

EcoVadis Corporate Social

Responsibility Assessment Gold

Medal

FTSE4Good Index

S&P 500 ESG Index

Citizenship

Civic 50

Corporate Responsibility

Magazine’s “100 Best Corporate

Citizens”

FORTUNE/Great Place to Work

“Best Workplaces for Giving Back”

PEOPLE’s “50 Companies That

Care”

20


Together, we will innovate for tomorrow, while

making a remarkable impact for millions today.

21


People. Passion. Possibilities.®

Documents

AbbVie: Who we are · AbbVie: Who we are US-ABBV-200135 AbbVie has as long history in healthcare dating back to 1888 with Abbott 3 130+ years of patient care Millions of lives touched